34 research outputs found

    The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study

    Get PDF
    Showing the effects of OP3-4 on the proliferation and differentiation of cartilage cell line ATDC5. A Results of proliferation assay on day 1 with the noninduction medium. B Alcian blue-positive area ratio in the cartilage induction medium on day 10. **p <0.01 vs. vehicle control, #p <0.05 vs. 100 ÎźM OP3-4. (JPEG 384 kb

    Low-temperature Magnetic Fluctuations Investigated by 125^{125}Te-NMR on the Uranium-based Superconductor UTe2_{2}

    Full text link
    To investigate the static and dynamic magnetic properties on the uranium-based superconductor UTe2_{2}, we measured the NMR Knight shift KK and the nuclear spin-lattice relaxation rate 1/T11/T_{1} in HaH \parallel a by 125^{125}Te-NMR on a 125^{125}Te-enriched single-crystal sample. 1/T1T1/T_1T in HaH \parallel a is much smaller than 1/T1T1/T_1T in HbH \parallel b and cc, and magnetic fluctuations along each axis are derived from the 1/T1T1/T_1T measured in HH parallel to all three crystalline axes. The magnetic fluctuations are almost identical at two Te sites and isotropic at high temperatures, but become anisotropic below 40 K, where heavy-fermion state is formed. The character of magnetic fluctuations in UTe2_2 is discussed with the comparison to its static susceptibility and the results on other U-based superconductors. It is considered that the magnetic fluctuations probed with the NMR measurements are determined by the magnetic properties inside the two-leg ladder formed by U atoms, which are dominated by the qaq_a = 0 ferromagnetic fluctuations.Comment: 10 pages, 6 figures

    125Te-NMR Study on a Single Crystal of Heavy Fermion Superconductor UTe2

    Full text link
    We report 125Te-NMR studies on a newly discovered heavy fermion superconductor UTe2. Using a single crystal, we have measured the 125Te-NMR Knight shift K and spin-lattice relaxation rate 1/T1 for fields along the three orthorhombic crystal axes. The data confirm a moderate Ising anisotropy for both the static (K) and dynamical susceptibilities (1/T1) in the paramagnetic state above about 20 K. Around 20 K, however, we have observed a sudden loss of NMR spin-echo signal due to sudden enhancement of the NMR spin-spin relaxation rate 1/T2, when the field is applied along the easy axis of magnetization (=a axis). This behavior suggests the development of longitudinal magnetic fluctuations along the a axis at very low frequencies below 20 K.Comment: 5 pages, 7 figures, accepted for publication in J. Phys. Soc. Jp

    大腸癌患者における術前血清インターロイキン6 が全身性炎症反応に与える影響についての検討

    Get PDF
    背景:全身性炎症反応は担癌患者における免疫応答を反映し,予後と関連することが報告されている.目的:血清インターロイキン6(IL-6)と臨床背景因子,とりわけ全身炎症性反応との関連について大腸癌患者を対象として検討すること.方法:大腸癌患者20 人の術前IL-6 濃度を測定し,L 群(低IL-6 群,11 人;IL-6<10 pg/ml)とH 群(高IL-6 群,9 人;IL-6 ≥ 10 pg/ml)の2 群に分けて臨床背景因子との関連について検討した.結果:血清C-reactive protein(CRP)値>1.0 mg/dl(P=0.038),血沈;9±7 versus 31±24(mm/ hr , P=0.031)が2 群間で有意差を認めたが,血小板数・血清アルブミン値・Glasgow Prognostic Score・好中球リンパ比に2 群間で有意差は認めなかった.2 群間の生存曲線による解析は,H 群はL 群に比べて予後不良の傾向を認めたが,統計学的な有意差は認められなかった.結論:高IL-6 血症は大腸癌術前患者における高CRP 値,血沈の亢進といった全身性炎症反応と相関し,予後との関連を示唆するものであった.Purpose:To investigate the relationship between preoperative serum interleukin-6(IL-6)level and clinical characteristics, including systemic inflammatory response(SIR)related characteristics, in colorectal cancer(CRC)patients undergoing surgery. Patients and methods:Twenty CRC patients who had undergone curative surgery were divided into two groups as follows:Group A(n=9);patients with low serum IL-6 level(<10 pg/ml)and Group B(n=11);patients with high serum IL-6 level(≥ 10 pg/ml). Chi squared test and Mann-Whitney test were performed to compare the clinical characteristics of two groups. Kaplan-Meier analysis and log rank test were used to compare the two groups in relation to overall survival. Results:Among a lot of clinical characteristics, there were significant differences between the two groups in serum C-reactive protein(CRP)level(0.2±0.1 versus 2.9 ±4.9 mg/dl, mean± SD, P=0.016)and erythrocyte sedimentation rate(ESR)(9±7 versus 31±24 mm/hr, mean ± SD, P=0.031). However, there was no significant difference between the two groups in overall survival. Conclusion:There is a close relationship between preoperative serum IL-6 level and SIR related clinical characteristics such as serum CRP level and ESR in CRC patients

    World Congress Integrative Medicine & Health 2017: Part one

    Get PDF

    Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study

    No full text
    Fosfomycin is a candidate drug for extended-spectrum &beta;-lactamase (ESBL)-producing bacteria, but its efficacy is yet to be investigated in dogs. This study investigated the urinary pharmacokinetic/pharmacodynamic (PK/PD) profile of fosfomycin orally administered at 80 mg/kg to six healthy dogs to assess its efficacy for canine urinary tract infections (UTIs) caused by ESBL-producing bacteria. Four strains of ESBL-producing Escherichia coli (ESBL-EC) characterized by fosfomycin minimum inhibitory concentrations (MICs) of 0.5, 1, 2, and 32 &micro;g/mL were used. Urine samples for the measurement of urinary drug concentrations and urinary bactericidal titers (UBTs) were obtained after drug administration. The urinary concentrations (&micro;g/mL, mean &plusmn; SE) were 1348.2 &plusmn; 163.5, 1191.6 &plusmn; 260.2, and 661.1 &plusmn; 190.4 at 0&ndash;4, 4&ndash;8, and 8&ndash;12 h, respectively, after drug administration. The mean urinary area under the curve during the test period (AUC0&ndash;12) of fosfomycin was estimated to be 12,803.8 &micro;g&middot;h/mL. The UBTs for all tested strains fluctuated closely with urine concentration during the test period (r = 0.944&ndash;1.000), and the area under the UBT-versus-time curve correlated with the urinary AUC/MIC of each strain (r = 0.991). According to the optimal urinary PK/PD target value, fosfomycin at 80 mg/kg twice daily may be suitable for the treatment of canine UTIs caused by ESBL-EC presenting MIC &le; 128 &micro;g/mL
    corecore